2'-Deoxyguanosine-5'-Monophosphate
Star0
Identification
- Generic Name
- 2'-Deoxyguanosine-5'-Monophosphate
- DrugBank Accession Number
- DB04457
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 347.2212
Monoisotopic: 347.063084339 - Chemical Formula
- C10H14N5O7P
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UThymidylate synthase Not Available Escherichia coli (strain K12) UDeoxynucleotide monophosphate kinase Not Available Enterobacteria phage T4 - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
Pathway Category Adenylosuccinate Lyase Deficiency Disease Xanthine Dehydrogenase Deficiency (Xanthinuria) Disease Xanthinuria Type I Disease Mitochondrial DNA Depletion Syndrome Disease Myoadenylate Deaminase Deficiency Disease Purine Metabolism Metabolic Purine Nucleoside Phosphorylase Deficiency Disease Lesch-Nyhan Syndrome (LNS) Disease Gout or Kelley-Seegmiller Syndrome Disease Mercaptopurine Action Pathway Drug action Adenine Phosphoribosyltransferase Deficiency (APRT) Disease Adenosine Deaminase Deficiency Disease AICA-Ribosiduria Disease Molybdenum Cofactor Deficiency Disease Azathioprine Action Pathway Drug action Thioguanine Action Pathway Drug action Xanthinuria Type II Disease - Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as purine 2'-deoxyribonucleoside monophosphates. These are purine nucleotides with monophosphate group linked to the ribose moiety lacking a hydroxyl group at position 2.
- Kingdom
- Organic compounds
- Super Class
- Nucleosides, nucleotides, and analogues
- Class
- Purine nucleotides
- Sub Class
- Purine deoxyribonucleotides
- Direct Parent
- Purine 2'-deoxyribonucleoside monophosphates
- Alternative Parents
- Purines and purine derivatives / Monoalkyl phosphates / Hydroxypyrimidines / N-substituted imidazoles / Tetrahydrofurans / Heteroaromatic compounds / Secondary alcohols / Oxacyclic compounds / Azacyclic compounds / Organopnictogen compounds show 3 more
- Substituents
- Alcohol / Alkyl phosphate / Aromatic heteropolycyclic compound / Azacycle / Azole / Heteroaromatic compound / Hydrocarbon derivative / Hydroxypyrimidine / Imidazole / Imidazopyrimidine show 17 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- deoxyguanosine phosphate, purine 2'-deoxyribonucleoside 5'-monophosphate, guanyl deoxyribonucleotide (CHEBI:16192) / Deoxyribonucleotides (C00362)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 7EAM4TG712
- CAS number
- 902-04-5
- InChI Key
- LTFMZDNNPPEQNG-KVQBGUIXSA-N
- InChI
- InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1
- IUPAC Name
- {[(2R,3S,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid
- SMILES
- NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0001044
- KEGG Compound
- C00362
- PubChem Compound
- 65059
- PubChem Substance
- 46507156
- ChemSpider
- 58570
- ChEBI
- 16192
- ChEMBL
- CHEMBL477487
- ZINC
- ZINC000001730395
- PDBe Ligand
- DGP
- PDB Entries
- 1dek / 1del / 1q9x / 1rnd / 1tlc / 1z4p / 2fc0 / 2jao / 2lrr / 2qca … show 12 more
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 2.67 mg/mL ALOGPS logP -1.9 ALOGPS logP -1.8 Chemaxon logS -2.1 ALOGPS pKa (Strongest Acidic) 1.24 Chemaxon pKa (Strongest Basic) 2.86 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 10 Chemaxon Hydrogen Donor Count 5 Chemaxon Polar Surface Area 181.52 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 73.55 m3·mol-1 Chemaxon Polarizability 29.72 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.8342 Blood Brain Barrier + 0.8619 Caco-2 permeable - 0.751 P-glycoprotein substrate Non-substrate 0.5222 P-glycoprotein inhibitor I Non-inhibitor 0.876 P-glycoprotein inhibitor II Non-inhibitor 0.9604 Renal organic cation transporter Non-inhibitor 0.9236 CYP450 2C9 substrate Non-substrate 0.8691 CYP450 2D6 substrate Non-substrate 0.8301 CYP450 3A4 substrate Substrate 0.5091 CYP450 1A2 substrate Non-inhibitor 0.8519 CYP450 2C9 inhibitor Non-inhibitor 0.9131 CYP450 2D6 inhibitor Non-inhibitor 0.9136 CYP450 2C19 inhibitor Non-inhibitor 0.9185 CYP450 3A4 inhibitor Non-inhibitor 0.9258 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9713 Ames test Non AMES toxic 0.7515 Carcinogenicity Non-carcinogens 0.8428 Biodegradation Not ready biodegradable 0.9826 Rat acute toxicity 2.3758 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9536 hERG inhibition (predictor II) Non-inhibitor 0.87
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 190.0317586 predictedDarkChem Lite v0.1.0 [M-H]- 191.0305586 predictedDarkChem Lite v0.1.0 [M-H]- 189.9032586 predictedDarkChem Lite v0.1.0 [M-H]- 166.65697 predictedDeepCCS 1.0 (2019) [M+H]+ 190.2560586 predictedDarkChem Lite v0.1.0 [M+H]+ 190.9179586 predictedDarkChem Lite v0.1.0 [M+H]+ 189.7512586 predictedDarkChem Lite v0.1.0 [M+H]+ 169.05252 predictedDeepCCS 1.0 (2019) [M+Na]+ 189.6755586 predictedDarkChem Lite v0.1.0 [M+Na]+ 190.0002586 predictedDarkChem Lite v0.1.0 [M+Na]+ 189.0882586 predictedDarkChem Lite v0.1.0 [M+Na]+ 174.96506 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsThymidylate synthase
- Kind
- Protein
- Organism
- Escherichia coli (strain K12)
- Pharmacological action
- Unknown
- General Function
- Thymidylate synthase activity
- Specific Function
- Provides the sole de novo source of dTMP for DNA biosynthesis. This protein also binds to its mRNA thus repressing its own translation.
- Gene Name
- thyA
- Uniprot ID
- P0A884
- Uniprot Name
- Thymidylate synthase
- Molecular Weight
- 30479.475 Da
References
2. DetailsDeoxynucleotide monophosphate kinase
- Kind
- Protein
- Organism
- Enterobacteria phage T4
- Pharmacological action
- Unknown
- General Function
- Atp binding
- Specific Function
- Phosphorylates dGMP, dTMP and 5-hydroxymethyl-dCMP while excluding dCMP and dAMP. The phosphorylation of 5-hydroxymethyl-dCMP represents the first step in the replacement of cytosine by hydroxymeth...
- Gene Name
- 1
- Uniprot ID
- P04531
- Uniprot Name
- Deoxynucleotide monophosphate kinase
- Molecular Weight
- 27328.9 Da
References
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52